Tsujita Eiji, Ikeda Yasuharu, Kinjo Nao, Yamashita Yo-Ichi, Hisano Terumasa, Furukawa Masayuki, Taguchi Ken-Ichi, Morita Masaru, Toh Yasushi, Okamura Takeshi
Am Surg. 2017 Jun 1;83(6):610-616.
To clarify the prognostic value of the postoperative blood neutrophil-to-lymphocyte ratio (NLR) in patients undergoing pancreatectomy for pancreatic carcinoma (PAC). A high preoperative NLR has been reported to be a predictor of poor survival in patients with various cancers including PAC. However, it has not been extensively examined in postoperative NLR after pancreatectomy for PAC. This retrospective study enrolled 86 patients who underwent pancreatectomy without preoperative therapy for PAC from 2005 to 2013. Clinicopathological parameters, including postoperative NLR, were evaluated to identify predictors of the overall and recurrence-free survival of patients after pancreatectomy. Univariate and multivariate analyses were performed, using the Cox proportional hazards model. Univariate and multivariate analyses showed that postoperative NLR at one month was an independent prognostic factor in the overall and recurrence-free survival of patients. The 3-year survival rate after pancreatectomy was as follows: 33.9 per cent in patients with a postoperative NLR of less than 3.0 at one month; and 7.3 per cent in those with a postoperative NLR of 3.0 or more at one month (P < 0.001). The overall survival rate after pancreatectomy in the NLR at one month ≥3.0 group was significantly lower than in the NLR at one month <3.0 group: one year, 42.6 versus 81.9 per cent; three year, 7.3 versus 33.9 per cent (P < 0.001). The results of the study suggest that the postoperative NLR at one month is an independent predictor of survival after pancreatectomy in patients with PAC.
为明确胰腺癌(PAC)胰十二指肠切除术后患者血液中性粒细胞与淋巴细胞比值(NLR)的预后价值。据报道,术前高NLR是包括PAC在内的多种癌症患者生存不良的预测指标。然而,PAC胰十二指肠切除术后的术后NLR尚未得到广泛研究。这项回顾性研究纳入了2005年至2013年期间86例未接受术前治疗的PAC患者,他们接受了胰十二指肠切除术。评估包括术后NLR在内的临床病理参数,以确定胰十二指肠切除术后患者总生存和无复发生存的预测指标。使用Cox比例风险模型进行单因素和多因素分析。单因素和多因素分析表明,术后1个月的NLR是患者总生存和无复发生存的独立预后因素。胰十二指肠切除术后3年生存率如下:术后1个月NLR小于3.0的患者为33.9%;术后1个月NLR为3.0或更高的患者为7.3%(P<0.001)。术后1个月NLR≥3.0组的胰十二指肠切除术后总生存率显著低于术后1个月NLR<3.0组:1年时分别为42.6%和81.9%;3年时分别为7.3%和33.9%(P<0.001)。研究结果表明,术后1个月的NLR是PAC患者胰十二指肠切除术后生存的独立预测指标。